MBC BioLabs Launches the Emerging Innovator Program, Sponsored by AbbVie
MBC BioLabs and AbbVie today announce the launch of the MBC BioLabs Emerging Innovator Program — an initiative to support emerging biotech innovators by expanding access to industry resources, mentorship and visibility. The program is designed for individuals who may be earlier in their careers or have had limited access to industry networks, startup experience or the broader life sciences innovation ecosystem.
Through generous backing from AbbVie, one company will be selected to receive an Emerging Innovator Golden Ticket — including one year of complimentary lab space at MBC BioLabs, plus access to shared instrumentation, mentorship, and our community of 230+ companies.
Ideal Emerging Innovator candidates are:
- Exceptional founders working across human health.
- Focused on innovative science with the potential to help patients.
- Teams that would benefit from access to MBC BioLabs’ research facilities and equipment.
- Pursuing bold, original ideas anywhere across the biotech and life science field.
The program seeks to accelerate biotech innovation by giving promising early-stage founders access to a fully equipped research facility and a community built to help them advance.
In the presentation, please address:
- What is the scientific insight and approach driving your company?
- What will be the impact of your innovation?
- How would winning the Golden Ticket help your company?
The selected finalist will be invited to present at MBC BioLabs at an event to be held on October 29. We look forward to receiving your application.
All the best of luck!
To apply, please upload your non-confidential company presentation by OCTOBER 2, 2026, 11:59 PM PDT.
About MBC BioLabs
At MBC BioLabs, we believe that startups are the greatest force for positive change in the world. We are dedicated to helping biotech startups succeed – we like to say that we enable awesome. We offer flexible and cost-effective lab space, complete with operational support and millions of dollars’ worth of state-of-the-art equipment and instrumentation, along with a vibrant community of like=minded individuals tackling the world’s largest problems.
We have helped launch and grow over 500 companies since opening in October of 2013, and together, MBC companies have initiated 176 clinical trials, introduced 135 products to market, and collectively raised over $20 billion. Learn more at mbcbiolabs.com.
About AbbVie
AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas including immunology, oncology and neuroscience – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Learn More: https://www.abbvie.com